Puchkova L V, Verbina I A, Gaĭtskoki V S, Neĭfakh S A
Biokhimiia. 1991 Dec;56(12):2261-9.
The ceruloplasmin (CP) interaction with the specific receptor localized on the erythrocyte membrane of healthy donors and of patients with hepatolenticular degeneration (HLD) was studied by using Scatchard analysis. It was found that in patients with the Wilson's disease the CP receptor is unaffected by the pathological process. The molecular mass of the erythrocyte receptor of CP is about 130 kDa. The CP binding to the specific receptor is followed by limited proteolysis of the latter. No CP binding to the receptor occurs in the presence of serine protease inhibitors. The CP-like protein previously detected in the sera of Wilson gene carriers can specifically interact with the CP receptor.
利用Scatchard分析研究了铜蓝蛋白(CP)与健康供体及肝豆状核变性(HLD)患者红细胞膜上特异性受体的相互作用。结果发现,在威尔逊病患者中,CP受体不受病理过程影响。CP的红细胞受体分子量约为130 kDa。CP与特异性受体结合后,后者会发生有限的蛋白水解。在丝氨酸蛋白酶抑制剂存在的情况下,CP不会与受体结合。先前在威尔逊基因携带者血清中检测到的CP样蛋白可与CP受体特异性相互作用。